-
  • Print this page
  • Change font size    

FDA's Electronic Reading Room - Warning Letters



Warning Letters Search Results


Search Criteria: Office is "Division of Drug Marketing, Advertising, and Communications"



   
Abbott Laboratories  07/14/2009  Division of Drug Marketing, Advertising, and Communications  DDMAC/Promotional Claims False & Misleading/Misbranded   No   
Abbott Laboratories  06/26/1998  Division of Drug Marketing, Advertising, and Communications  Promotional & Labeling Violations   No   
Allergan Inc.  08/17/2009  Division of Drug Marketing, Advertising, and Communications  Labeling/Promotional Claims False & Misleading/Misbranded   No   
Amersham Healthcare Inc.  08/21/1997  Division of Drug Marketing, Advertising, and Communications  Devices/Imaging Kit  No   
Amgen Inc.  02/18/2005  Division of Drug Marketing, Advertising, and Communications  Labeling/Promotional Claims False & Misleading/Misbranded   No   
AstraZeneca  09/01/2000  Division of Drug Marketing, Advertising, and Communications  Diprivan Infectable Emulsion/Misbranded/False or Misleading Promotional Labeling   No   
Bioniche Pharma Group 9/14/09  09/14/2009  Division of Drug Marketing, Advertising, and Communications  Labeling/Promotional Claims False & Misleading/Misbranded   No   
Bioniche Pharma Group Limited  04/04/2006  Division of Drug Marketing, Advertising, and Communications  Labeling/Promotional Claims False & Misleading   No   
Boehringer Ingelheim Pharmaceuticals, Inc.  09/23/2004  Division of Drug Marketing, Advertising, and Communications  Labeling/False & Misleading  No   
Bradley Pharmaceuticals, Inc.  11/04/2004  Division of Drug Marketing, Advertising, and Communications  Promotional Claims/False & Misleading/Misbranded   No   
Bristol-Myers Squibb Company  08/07/2003  Division of Drug Marketing, Advertising, and Communications  Drug Labeling/Promotional Claims/Misbranded   No   
Bristol-Myers Squibb Company  10/27/1999  Division of Drug Marketing, Advertising, and Communications  Unapproved Drug Use/Hydrea & Droxia   No   
Celgene Corporation  04/21/2000  Division of Drug Marketing, Advertising, and Communications  Thalomid/Promotional Activities for Unapproved Uses   No   
Critical Therapeutics, Inc.  11/08/2005  Division of Drug Marketing, Advertising, and Communications  Promotional Claims False & Misleading/Misbranded   No   
Dey Laboratories  09/01/1999  Division of Drug Marketing, Advertising, and Communications  Promotional Material and Activities   No   
Forest Laboratories Inc.  06/26/1998  Division of Drug Marketing, Advertising, and Communications  Labeling  No   
G.D. Searle & Co.  05/26/1998  Division of Drug Marketing, Advertising, and Communications  Labeling  No   
G.D. Searle & Co.  11/21/1997  Division of Drug Marketing, Advertising, and Communications  Drug Products/Advertising  No   
Glaxo Wellcome Inc.  08/18/1999  Division of Drug Marketing, Advertising, and Communications  Television Broadcast Advertisement/Flonase   No   
GlaxoSmithKline  07/17/2001  Division of Drug Marketing, Advertising, and Communications  Promotional Activities  No   
GlaxoSmithKline  06/30/2006  Division of Drug Marketing, Advertising, and Communications  Labeling/False & Misleading Claims/Misbranded   No   
GlaxoSmithKline  01/31/2005  Division of Drug Marketing, Advertising, and Communications  Labeling/Promotional Claims False & Misleading/Misbranded   No   
Hoffman-La Roche Inc  05/29/2003  Division of Drug Marketing, Advertising, and Communications  Misleading Promotional Materials   No   
Hoffmann-LaRoche Inc.  03/05/1998  Division of Drug Marketing, Advertising, and Communications  Labeling and Promotional Violations   No   
Janssen Pharmaceutica, Inc.  09/02/2004  Division of Drug Marketing, Advertising, and Communications  Promotional Claims/False & Misleading   No   
Janssen Pharmaceutica, Inc.  04/19/2004  Division of Drug Marketing, Advertising, and Communications  Risperdal/Dear Healthcare Provider Letter/False, Misleading Claims   No   
King Pharmaceuticals Inc  03/24/2008  Division of Drug Marketing, Advertising, and Communications  Drug File Card/False & Misleading Claims/Misbranded   No   
Kos Pharmaceuticals, Inc.  07/13/2001  Division of Drug Marketing, Advertising, and Communications  Advertising/Post-Marketing Reporting Requirements   No   
Medicis Pharmaceutical Corporation  12/22/1998  Division of Drug Marketing, Advertising, and Communications  Dynacin  No   
Merck & Co., Inc.  09/17/2001  Division of Drug Marketing, Advertising, and Communications  Vioxx/Promotional Activities & Materials/False & Misleading   No   
Nexstar Pharmaceuticals Inc.  02/21/1997  Division of Drug Marketing, Advertising, and Communications  False and Misleading Advertising   No   
Novartis Pharmaceuticals Corporation  01/21/1999  Division of Drug Marketing, Advertising, and Communications  Television Broadcasting Advertisement/Lescol   No   
Novartis Pharmaceuticals Corporation  04/21/2004  Division of Drug Marketing, Advertising, and Communications  Diovan/False & Misleading Promotional Claims   No   
Ortho-McNeil Pharmaceutical, Inc.  09/15/2004  Division of Drug Marketing, Advertising, and Communications  Promotional Claims/False & Misleading   No   
Pedinol Pharmacal Inc  08/20/2009  Division of Drug Marketing, Advertising, and Communications  Labeling/Promotional Claims False & Misleading/Misbranded   No   
Pharmacia Corporation  02/01/2001  Division of Drug Marketing, Advertising, and Communications  Celebrex/Promotiona Activities Materials/False Misleading Etc.   No   
PrimaPharm Inc  06/29/2006  Division of Drug Marketing, Advertising, and Communications  Labeling/False & Misleading Claims/Misbranded   No   
Purdue Frederick Company  11/20/1996  Division of Drug Marketing, Advertising, and Communications  Drug Products/Imorphint Sulfate Tablets   No   
Purdue Pharma L.P.  01/17/2003  Division of Drug Marketing, Advertising, and Communications  Oxycontin/False and Misleading Advertising   No   
Schering Corporation  07/31/1997  Division of Drug Marketing, Advertising, and Communications  Nasal Spray  No   
Smithkline Beecham Pharmaceuticals  03/13/1998  Division of Drug Marketing, Advertising, and Communications  Drug Products  No   
Sonus Pharmaceuticals Inc.  03/26/1998  Division of Drug Marketing, Advertising, and Communications  Drug Products  No   
Teva Marion Partners  08/27/1998  Division of Drug Marketing, Advertising, and Communications  Labeling & Promotional Claims  No   
Watson Pharmaceuticals Inc.  12/22/1998  Division of Drug Marketing, Advertising, and Communications  Condylox Gel/Advertising and Labeling   No   
Zeneca Pharmaceuticals  11/24/1998  Division of Drug Marketing, Advertising, and Communications  Federal Food Drug and Cosmetic Act Violations   No   

Prev  |  Next  |  [1]  |  First  |  Last  |  All
 
-
-
-
-
-